Research and Markets: GSK’s Flovent (Asthma) – Forecast and Market Analysis … – Business Wire (press release)

Research and Markets: GSK's Flovent (Asthma) – Forecast and Market Analysis
Business Wire (press release)
Originally approved by the Food and Drug Administration (FDA) in 1996, GSK's Flovent (fluticasone propionate) is a synthetic ICS therapy with potent anti-inflammatory activity. It is used for the maintenance treatment of asthma prophylactically in
Research and Markets: GSK's Bosatria (Mepolizumab) Asthma Treatment Rock Hill Herald (press release)

all 4 news articles »

View full post on asthma – Google News

Research and Markets: Roche’s Quilizumab (Asthma) – Forecast and Market … – Business Wire (press release)

Research and Markets: Roche's Quilizumab (Asthma) – Forecast and Market
Business Wire (press release)
IgE is important in the development of allergic asthma, as it binds to mast cells and basophils, which play a significant role in the pathogenesis of asthma. IgE ultimately triggers the release of histamines, prostaglandins, and leukotrienes, which
Research and Markets: Cinquil (Reslizumab) Asthma Treatment – Forecast and Rock Hill Herald (press release)
Research and Markets: Roche's Lebrikizumab (Asthma) Treatment – Forecast DigitalJournal.com

all 3 news articles »

View full post on asthma – Google News

$2.9M NIH Grant Supports Research to Help Urban Teens Manage Asthma – University of Rochester Newsroom

$2.9M NIH Grant Supports Research to Help Urban Teens Manage Asthma
University of Rochester Newsroom
Managing persistent asthma can be a challenge for adults, but it's even more difficult for teenagers learning to take control of their health. Peer pressure, feelings of embarrassment or insecurity, and busy school and activity schedules, are just some

View full post on asthma – Google News

Research and Markets: Roche/Genentech/Novartis’ Asthma Treatment – Xolair … – Business Wire (press release)

Research and Markets: Roche/Genentech/Novartis' Asthma Treatment – Xolair
Business Wire (press release)
Roche/Genentech/Novartis' Xolair (omalizumab) is currently the only FDA-approved biologic used in the treatment of asthma. This drug is a recombinant humanized mAb that binds and neutralizes IgE with the same high affinity as its cognate receptor, FceRI.
Research and Markets: Merck's Dulera Asthma Treatment – Forecast and Market DigitalJournal.com

all 2 news articles »

View full post on asthma – Google News

Seven developments in asthma research – Healio


2 Minute Medicine

Seven developments in asthma research
Healio
Recent studies on asthma have focused on partial asthma control therapy and the use of mepolizumab to reduce exacerbations and glucocorticoid dosing in patients with eosinophilic asthma. Presentations at the European Respiratory Society International …
Mepolizumab reduces exacerbations in severe eosinophilic asthma [MENSA trial]2 Minute Medicine

all 2 news articles »

View full post on asthma – Google News

Research and Markets: PharmaPoint: Asthma – 5EU Drug Forecast and Market … – Rock Hill Herald (press release)

Research and Markets: PharmaPoint: Asthma – 5EU Drug Forecast and Market
Rock Hill Herald (press release)
The relatively slow growth of the German market compared with the French, Spanish, and UK markets is attributable to the slightly decreasing prevalence of asthma in this country over the forecast period. Advair's active patent on the Diskus delivery

and more »

View full post on asthma – Google News

Nemours research trial aims to improve asthma treatment – WJXT Jacksonville


WJXT Jacksonville

Nemours research trial aims to improve asthma treatment
WJXT Jacksonville
“In the beginning, it was 'What happens in an asthma attack?' like on the daily and nightly report things I have to do. … They ask you certain questions like, 'Have you had an asthma attack today? How many doses of your medicine have you taken

and more »

View full post on asthma – Google News

Overweight children face risk of getting asthma: Research – Daily News & Analysis


Daily News & Analysis

Overweight children face risk of getting asthma: Research
Daily News & Analysis
If your child is overweight, there's one more reason for you to worry. In addition to the usual, risk of obesity and its associated health complications there's a risk of him/her getting asthma too. And if your child is overweight and has asthma too

View full post on asthma – Google News